Direct beauty seller Nu Skin Enterprises’ (NUS) stock price rose fourfold in 2013 from previous year’s lows due to unfounded fears of being associated with Herbalife Ltd. (HLF), says Andrew Absler, a Senior Research Analyst at Lombardia Capital Partners, LLC, and Portfolio Manager for the Small Cap Value Portfolio.
“The fears proved unfounded, and the stock experienced both multiple expansion and tremendous earnings growth. Today the stock is in excess of $130, which is approximately a fourfold increase from its lows,” Absler explained.
FOR MORE INFORMATION ABOUT THIS INTERVIEW CLICK HERE.
Absler says about 10% of Nu Skin sales for its beauty and personal care products come from North America, and he says Asian markets currently provide significant growth for the direct seller.
Absler commented that Nu Skin’s stock performance in 2013 made it Small Cap Value Portfolio’s best performer. He added that others were not as keen on the stock during the controversy, but Lombardia did not follow the crowd. “Steve Malcolm is the primary analyst on the stock, and to his credit he stuck with the name during the controversy and pushed us to buy more when the stock was weak,” Absler said.
Nu Skin Enterprises, Inc. (NUS) Prepped for Growth with Innovative Health Care Products
June 17, 2014
Mizuho Americas Stock Picker Sees Biotech M&A Prospects as Drug Trials Proceed and Stock Prices Stall
October 24, 2019
Core & Main (NYSE:CNM) is a Top Stock Pick from the Financial Times/Starmine Top Stock Picker in Construction Materials
August 30, 2023
Caterpillar Inc. (CAT) Eyes $110 Stock Price, $7 EPS as Equipment Production Increases in 2013
May 29, 2013
First Acceptance Corporation (FAC) Stock Returned 60% in 2013
January 23, 2014
